The report shows that the number of 12- to 25-year-olds using any GLP-1 drug including older medications first approved to treat diabetes in 2005 and for weight loss in 2014 climbed from about 8,700 a month in 2020 to more than 60,000 a month in 2023, a nearly 600% increase
For production-scale orders, each shipment is usually between 25 and 100 kilograms, and bigger contracts can get savings on the price
Semaglutide might not be suitable for people with a family history of specific cancers or severe gastrointestinal diseases
Sublingual and buccal delivery Sublingual semaglutide and tirzepatide drops represent another non-injectable approach
(Yes, another lovely change with menopause)
Acute Fat Oxidation and Energy Expenditure Acute single administration of AOD9604 in wild-type mice produced a significant increase in fat oxidation and energy expenditure, with an associated reduction in glucose oxidation